Peel Hunt Reiterates “Buy” Rating for Genedrive (GDR)

Share on StockTwits

Genedrive (LON:GDR)‘s stock had its “buy” rating restated by investment analysts at Peel Hunt in a report released on Wednesday.

Shares of Genedrive opened at GBX 30.50 ($0.39) on Wednesday, Marketbeat reports. Genedrive has a one year low of GBX 25 ($0.32) and a one year high of GBX 44.50 ($0.58).

Genedrive Company Profile

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Recommended Story: Market Capitalization – What it Means for Investors

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with's FREE daily email newsletter.

Leave a Reply